Activating CNS agents - PowerPoint PPT Presentation

1 / 48
About This Presentation
Title:

Activating CNS agents

Description:

Activating CNS agents Lector prof. Posokhova K.A. Properties of nootropic drugs Improvement of brain blood circulation, promotion of collaterals development ... – PowerPoint PPT presentation

Number of Views:228
Avg rating:3.0/5.0
Slides: 49
Provided by: inte103
Category:

less

Transcript and Presenter's Notes

Title: Activating CNS agents


1
  • Activating CNS agents

Lector prof. Posokhova K.A.
2
PSYCHOTROPIC DRUGS
  • Drugs with depressive type of actoin
  • Neuroleptics (antipsychotic)
  • Tranquilizers (anxiolytics)
  • Sedative drugs
  • Normotymics (tymoleptics, tymoanaleptics)
  • Drug with stimulative action
  • Antidepressants
  • Psychomotor stimulants
  • Nootropic drugs
  • Drugs which increase general tone (adaptogens)
  • Psychotomimetics (psychodysleptics)
  • LSD
  • Cannabis sativa L.

3
ANTIDEPRESSANTS
4
WHO 3-6 of Earth population suffer from
depression
  • Depression and somatic-vegetative symptoms
    which accompany depression are quite often
    psychical disorders which happen in general
    medical practice.
  • There are
  • Endogen (psychogenic) depression schizophrenia,
    maniac-depressive psychosis
  • Secondary (somatogenic) depression organic
    diseases (oncology patients, hypertension, ulcer
    disease, climacteric disorders etc.)

5
More than 50 of patients with depressive
disorders dont realize that they have any
psychological problems and complain only on
certain somatic discharges
  • Most frequent complaints of patients with
    depression
  • Feeling of hopelessness, indifference, fear,
    panic attacks,
  • tiredness, weakness, headache, dizziness, dream
    disorders, dyspepsia, unpleasant feelings and
    pain in different parts of the body
  • Depressive conditions mask as vegetal-vascular,
    neuro-circulative dystonia (various vegetative
    disorders), gastro-intestinal pathology,
    pathology of cardio-vascular, respiratory
    systems, manifest as diskinesia, functional motor
    disorders, insomnia, toothache, disorders of
    sexual activity, recidivate eczema and many
    other disorders

6
Function of adrenergic synapse in physiological
conditions
7
ANTIDEPRESSANTS
  • Drugs which inhibit neuronal uptake of monoamines
  • Nonselective action (block uptake of
    noradrenaline and serotonine) imisin,
    amitriptilin
  • Selective action ?) heterocyclic compounds
    (block neuronal uptake of noradrenaline)
    amoxapin, maprotilin (ludiomil) ?) selective
    blockers of neuronal uptake of serotonin
    fluoxetin (prozak, framex), sertralin (zoloft),
    paroxetin (rexetin)
  • Inhibitors of monoaminoxidase (IMAO)
  • nonselective (block ???-? and ???-?) ?)
    irreversible action nialamid b) reversible
    action transamin
  • Selective ???? (block ???-?) moklobemid,
    pirasidol

8
(No Transcript)
9
Blockers of neuronal uptake of serotonin
  • Modern point of view on mechanism of development
    of depression
  • Primary deficiency of serotonin in synaptic cleft
  • Compensatory growing of quantity and sensitivity
    of postsynaptic 5-??2 receptors
  • Compensatory decreasing of quantity and
    sensitivity of presynaptic 5-??1 receptors in
    hippocampus and nuclei row (these structures play
    an important role ?n development of depression)

10
Blockers of neuronal uptake of serotonin
fluoxetin, sertralin, paroxetin
  • Mechanism of action
  • Increasing of active concentration of serotonin
    in synaptic cleft on a level of postsynaptic
  • 5-??2 serotonin receptors of cerebral structures

11
Blockers of neuronal uptake of serotonin
fluoxetin, sertralin, paroxetin
12
Mechanism of action of IMAO
13
Usage of antidepressants
  • Schizophrenia, MDS
  • Atherosclerosis of brain
  • Reactive depressions
  • Parkinsonism
  • Organic diseases of CNS
  • Oncology patients
  • General somatic diseases

14
Psychotropic action of antidepressants
  • Drugs with psychosedative action
  • ?mitriptilin, maprotilin, asafen, fluvoxamin
  • 2. Drugs with psychostimulative action
  • Imisin, nialamid, fluoxetin
  • 3. Drugs with regulative influence
  • Pirasidol

15
Principles of antidepressants usage
  • Endogen depression the deeper it is, the larger
    doses, rate of their increasing and duration of
    treatment should be administered
  • Step-by-step dose increasing till obtaining of
    effect, administration of effective dose during
    4-6 weeks 3-6 months, gradual decreasing of
    dose (during 5-6 weeks)
  • Effect can appear only after 7-14 days after
    beginning of therapy (this fact should be taken
    into consideration in patients with suicidal
    dispositions)
  • In case of rapid abolishing withdrawal syndrome
    may develop

16
Side effects of antidepressants
  • ?-cholinoblocking action dry mouth, increasing
    of intraocular pressure, disturbance of
    accommodation, constipation, ischuria (important
    in a case of adenoma of prostatic gland!),
    tremor, hallucinations, disorders of
    consciousness, excitation
  • Alpha-adrenoblocking, papaverine-like effect
    sharp hypotension, orthostatic collapse
    (especially in combination of amitriptiline with
    clopheline), for correction of which
    adrenomimetics cannot be used (it is necessary to
    increase volume of circulating blood, put the
    legs up)

17
Side effects of antidepressants
  • Acute attacks of epilepsy
  • Cardiotoxic action (sudden death), three- cyclic
    antidepressants increase arrhythmogenic activity
    of drugs for general anesthesia, antihistamines
    etc.
  • Combination of three-cyclic antidepressants with
    IMAO is absolutely contraindicated danger of
    development of hypertensive crisis, seizures,
    rapid excitation, tachycardia, cardiac
    arrhythmias, increasing of temperature

18
Rules of transferring from one kind of
antidepressants to another
  • From three-cyclic to IMAO break time 2-3 days
  • From IMAO to three-cyclic break time not less
    than 2 weeks

19
It is absolutely contraindicated to administer
adreno(sympato)mimetics in case of treatment with
antidepressants
  • Even small doses of adrenomimetic
    (sympatomimetic) substances in such patient can
    cause hypertensive crisis
  • Nose drops for rhinitis
  • If few drops were added to solutions of local
    anesthetics
  • In case of administration of drugs which contain
    pseudoephedrine (they are widely used for cold at
    nowadays)

20
Diet in case of administration of IMAO
  • It is necessary to exclude such products which
    contain
  • DOPA and thiramine (which is formed from casein
    during the process of transforming under the
    influence of bacteria)
  • aged cheese, kefir
  • Marinated herring
  • Smoked meat, fish
  • Red vine, beer, yeast
  • Beans
  • oranges, tangerines, lemons, grape, bananas,
  • chocolate, caviar (red and black)
  • Any BAA are also dangerous
  • In case of treatment with IMAO new products
    should be introduced into ration very carefully

21
(No Transcript)
22
  • In case of administration of inhibitors of uptake
    of serotonin the previously indicated side
    effects are observed much more rarely
  • Administration of antidepressants with any other
    drugs should be performed only after precise
    studying of possible negative consequences of
    their interaction

23
PSYCHOMOTOR STIMULANTS
24
PSYCHOMOTOR STIMULANTS
  • Derivatives of purine caffeine
  • Phenilalkilamines phenamine (amphetamine)
  • Phenilalkilsydnonimins - sydnocarb

25
Properties of psychomotor stimulants
  • Stimulate intellectual activity, speed up
    thinking processes, temporarily eliminate
    tiredness, somnolence
  • Eliminate such manifestations of neurosis as
    subdepression, fatigue, retardness
  • Arent able to eliminate endogen depression,
    which accompanies psychical diseases

26
Caffeine
  • Mechanism of action
  • Binds to adenosine (purine) receptors in
    brain (endogen ligand of these receptors
    adenosine decreases processes of excitation in
    CNS)
  • Inhibiting of phosphodiesterase, which leads to
    accumulation of cAMP and stimulation of many
    physiological processes and metabolism

27
Caffeine
28
Usage of psychostimulating influence of caffeine
  • For stimulation of psychological processes,
    workability, to eliminate somnolence
  • Enuresis, narcolepsy
  • In case of poisoning with alcohol
  • To speed up awakening after narcosis

29
Influence of caffeine on
cardiac-vascular system
  • Vessels
  • Stimulation of vasomotor center contraction of
    vessels, increasing of AP
  • Peripheral myotropic spasmolytic action
    dilation of vessels, decreasing of AP
  • Heart
  • Central action (increasing of n. vagus tone)
    bradycardia
  • Peripheral action (direct influence on heart)
    tachycardia, possible extrasystolia

30
Influence of caffeine on cardio-vascular system
  • Contraction of brain vessels
  • Dilation of kidney vessels, increasing of
    diuresis
  • Dilation of coronary vessels
  • In case of depression of centers of brain stem
    (medulla oblongata) caffeine shows stimulating
    properties, increases blood pressure, stimulates
    breathing analeptic action

31
SIDE EFFECTS OF CAFFEINE
  • If administered regularly psychological
    addiction theism, which is accompanied by
    development of abstinent syndrome (retardness,
    fatigue, somnolence, depression)
  • Tolerance
  • Teratogenic action (innate abnormalities)
  • Increasing of frequency of IHD, essential
    hypertension
  • Acute attacks of ulcer disease (it increases
    gastric secretion)
  • Acute poisoning in case of overdosing

32
NOOTROPIC DRUGS(NEUROMETABOLIC
CEREBROPROTECTORS)
33
Neurometabolic cerebroprotectors
  • Derivatives of pyrrolidone pyracetam
    (nootropil)
  • Derivatives of GABA aminalon, sodium
    oxybutyrate
  • Neuropeptides melatonin, sinacten-depot
  • Cerebrovascular drugs sermion (nicergolin),
    cavinton (vinpocetin), stugeron (cinnarisin),
    pentoxyphylline (trental, agapurine), xantynole
    nicotinate
  • Derivatives of piridoxine piritinol
    (encephabol)
  • Antioxidants mexidol, tocopherole acetate
  • Other cerebrolysine, actovegin, solkoseryl,
    plant preparations

34
Properties of nootropic drugs
  • Improvement of brain blood circulation, promotion
    of collaterals development
  • Psychostimulating effect, antiasthenic action
  • Sedative, antidepressive action
  • Antiepileptic, antiparkinsonic action
  • Nootropic action
  • Mnemotropic action
  • Vasovegetative action
  • Antihypoxic action

35
Administration of nootropic drugs
  • Atherosclerosis of brain, vascular parkinsonism,
    Alzheimer's disease
  • Disorders of brain blood circulation in case of
    traumas and intoxications, vascular diseases of
    brain
  • Diseases of CNS, accompanied by decreasing of
    intellect, memory
  • Disorders of psychology (in elderly with
    schizophrenia, depressions)
  • To decrease manifestations of abstinence
    (alcoholism, drug addiction)
  • In neurology (neurasthenia, migraine, neuralgias,
    radiculitis)
  • In pediatrics in case of mental insufficiency

36
Piracetam (nootropil)
37
Cerebrolysin
38
Cinnarizin (stugeron)
39
ADAPTOGENS
40
Adaptogens
  • Drugs of
  • Ginseng, Schizandrum, Rodiola, Eleutherococcus,
    Leusea, Echinacea
  • Apilac, propolis, mumie,
  • heparin, dybazol

41
GINSENG
42
RODIOLA
43
Eleutherococc
44
Schizandrum
45
Echinacea purpurea Maxima
46
ADAPTOGENS
  • Increase general resistance of the organism
    towards unfavorable factors
  • Stimulating action
  • Antistress action
  • Anabolic action

47
Side effects of adaptogens
  • Increasing of AP
  • disturbance of sleep if administered in evening
    time, overwhelming excitation, psychical
    dependence

48
Analeptics (Bemegridum, Camphora, Cordiaminum)
Camphora
Write a Comment
User Comments (0)
About PowerShow.com